Published: August 2023
Despite the growing adoption, limitations of conventional antibody drug conjugates and related technologies, such as low safety and efficacy, unstable DAR and off-site toxicity, have prompted innovators to look out for more advanced antibody drug conjugate linker and conjugation technologies. Driven by the growing demand for antibody drug conjugates and the ongoing technological advancements, the ADC linker and conjugation technologies market is poised to experience noteworthy growth over the coming years.
To order this 400+ page report, which features 140+ figures and 200+ tables, please visit this link
Majority (45%) of the ADC linker and conjugation technology providers are headquartered in North America. Further, ~50% of the technology providers are start-ups with employee count ranging between 2-50.
Majority (54%) of the technologies are third-generation. Further, 50% of the technologies offer chemical based site specific conjugation of antibodies to potent payloads.
Of these, 47% of the antibody drug conjugates are under discovery / pre-clinical stage of development. More than 75% of the antibody drug conjugates are being developed for targeting solid tumors, including breast cancer and lung cancer.
Close to 60% of the partnerships were established for licensing of ADC linker and conjugation technologies for development of various novel targets. Further, around 11% of the total deals inked between stakeholders in this industry were intended for research and development purposes.
Technology out-licensing is the most prominent business strategy adopted by players in this industry. This is followed by collaborative research and product out-licensing business strategies.
Close to 60% of the patent applications have been filed post 2020. It is worth noting that around 35% of the patents were filed by / granted to the players headquartered in Asia-Pacific region, followed by North America.
Currently, North America captures the highest market share (~40%), in terms of revenues generated from technology licensing deals, while the ADC linker and conjugation technologies market in Asia-Pacific and rest of the world is likely to grow at a CAGR of ~13%, till 2035.
To request a sample copy / brochure of this report, please visit this link
The financial opportunity within the ADC technology market has been analyzed across the following segments:
The research includes brief profiles of key players offering ADC linker and conjugation technologies; each profile features, an overview of the company, details related to its offerings, recent developments and an informed future outlook:
For additional details, please visit https://www.rootsanalysis.com/reports/view_document/adc-technologies-market/287.html or email firstname.lastname@example.org
+1 (415) 800 3415
+44 (122) 391 1091
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES